-DOCSTART- -X- O
Chronic -X- _ B-Patient
obstructive -X- _ I-Patient
pulmonary -X- _ I-Patient
disease -X- _ I-Patient
( -X- _ I-Patient
COPD -X- _ I-Patient
) -X- _ I-Patient
is -X- _ O
characterized -X- _ O
by -X- _ O
chronic -X- _ O
airway -X- _ O
inflammation -X- _ O
and -X- _ O
/ -X- _ O
or -X- _ O
airflow -X- _ O
limitation -X- _ O
due -X- _ O
to -X- _ O
pulmonary -X- _ O
emphysema. -X- _ O
Chronic -X- _ B-Patient
bronchitis -X- _ I-Patient
, -X- _ I-Patient
pulmonary -X- _ I-Patient
emphysema -X- _ I-Patient
, -X- _ I-Patient
and -X- _ I-Patient
bronchial -X- _ I-Patient
asthma -X- _ I-Patient
may -X- _ O
all -X- _ O
be -X- _ O
associated -X- _ O
with -X- _ O
airflow -X- _ O
limitation -X- _ O
; -X- _ O
therefore -X- _ O
, -X- _ O
exacerbation -X- _ O
of -X- _ O
asthma -X- _ O
may -X- _ O
be -X- _ O
associated -X- _ O
with -X- _ O
the -X- _ O
pathophysiology -X- _ O
of -X- _ O
COPD. -X- _ O
Furthermore -X- _ O
, -X- _ O
recent -X- _ O
studies -X- _ O
have -X- _ O
suggested -X- _ O
that -X- _ O
the -X- _ O
exacerbation -X- _ B-Outcome
of -X- _ I-Outcome
asthma -X- _ I-Outcome
, -X- _ I-Outcome
namely -X- _ I-Outcome
virus-induced -X- _ I-Outcome
asthma -X- _ I-Outcome
, -X- _ I-Outcome
may -X- _ I-Outcome
be -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
a -X- _ I-Outcome
wide -X- _ I-Outcome
variety -X- _ I-Outcome
of -X- _ I-Outcome
respiratory -X- _ I-Outcome
viruses. -X- _ I-Outcome
COPD -X- _ O
and -X- _ O
asthma -X- _ O
have -X- _ O
different -X- _ O
underlying -X- _ O
pathophysiological -X- _ O
processes -X- _ O
and -X- _ O
thus -X- _ O
require -X- _ O
individual -X- _ O
therapies. -X- _ O
Exacerbation -X- _ B-Patient
of -X- _ I-Patient
both -X- _ I-Patient
COPD -X- _ I-Patient
and -X- _ I-Patient
asthma -X- _ I-Patient
, -X- _ O
which -X- _ O
are -X- _ O
basically -X- _ O
defined -X- _ O
and -X- _ O
diagnosed -X- _ O
by -X- _ O
clinical -X- _ O
symptoms -X- _ O
, -X- _ O
is -X- _ O
associated -X- _ B-Outcome
with -X- _ I-Outcome
a -X- _ I-Outcome
rapid -X- _ I-Outcome
decline -X- _ I-Outcome
in -X- _ I-Outcome
lung -X- _ I-Outcome
function -X- _ I-Outcome
and -X- _ I-Outcome
increased -X- _ I-Outcome
mortality. -X- _ I-Outcome
Similar -X- _ O
pathogens -X- _ O
, -X- _ O
including -X- _ O
human -X- _ B-Outcome
rhinovirus -X- _ I-Outcome
, -X- _ I-Outcome
respiratory -X- _ I-Outcome
syncytial -X- _ I-Outcome
virus -X- _ I-Outcome
, -X- _ I-Outcome
influenza -X- _ I-Outcome
virus -X- _ I-Outcome
, -X- _ I-Outcome
parainfluenza -X- _ I-Outcome
virus -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
coronavirus -X- _ I-Outcome
, -X- _ I-Outcome
are -X- _ I-Outcome
also -X- _ I-Outcome
frequently -X- _ I-Outcome
detected -X- _ I-Outcome
during -X- _ I-Outcome
exacerbation -X- _ I-Outcome
of -X- _ I-Outcome
asthma -X- _ I-Outcome
and -X- _ I-Outcome
/ -X- _ I-Outcome
or -X- _ I-Outcome
COPD. -X- _ I-Outcome
Immune -X- _ O
response -X- _ O
to -X- _ O
respiratory -X- _ O
viral -X- _ O
infections -X- _ O
, -X- _ O
which -X- _ O
may -X- _ O
be -X- _ O
related -X- _ O
to -X- _ O
the -X- _ O
severity -X- _ O
of -X- _ O
exacerbation -X- _ O
in -X- _ O
each -X- _ O
disease -X- _ O
, -X- _ O
varies -X- _ O
in -X- _ O
patients -X- _ B-Patient
with -X- _ I-Patient
both -X- _ I-Patient
COPD -X- _ I-Patient
and -X- _ I-Patient
asthma. -X- _ I-Patient
In -X- _ O
this -X- _ O
regard -X- _ O
, -X- _ O
it -X- _ O
is -X- _ O
crucial -X- _ O
to -X- _ O
recognize -X- _ O
and -X- _ O
understand -X- _ O
both -X- _ O
the -X- _ O
similarities -X- _ O
and -X- _ O
differences -X- _ O
of -X- _ O
clinical -X- _ O
features -X- _ O
in -X- _ O
patients -X- _ B-Patient
with -X- _ I-Patient
COPD -X- _ I-Patient
and -X- _ I-Patient
/ -X- _ I-Patient
or -X- _ I-Patient
asthma -X- _ I-Patient
associated -X- _ O
with -X- _ O
respiratory -X- _ O
viral -X- _ O
infections -X- _ O
, -X- _ O
especially -X- _ O
in -X- _ O
the -X- _ O
exacerbative -X- _ O
stage. -X- _ O
In -X- _ O
relation -X- _ O
to -X- _ O
definition -X- _ O
, -X- _ O
epidemiology -X- _ O
, -X- _ O
and -X- _ O
pathophysiology -X- _ O
, -X- _ O
this -X- _ O
review -X- _ O
aims -X- _ O
to -X- _ O
summarize -X- _ O
current -X- _ O
knowledge -X- _ O
concerning -X- _ O
exacerbation -X- _ B-Patient
of -X- _ I-Patient
both -X- _ I-Patient
COPD -X- _ I-Patient
and -X- _ I-Patient
asthma -X- _ I-Patient
by -X- _ O
focusing -X- _ O
on -X- _ O
the -X- _ O
clinical -X- _ O
significance -X- _ O
of -X- _ O
associated -X- _ O
respiratory -X- _ O
virus -X- _ O
infections -X- _ O
. -X- _ O

